Adam Woodrow

VP & Chief Commercial Officer, Paratek Pharmaceuticals, Inc.

Companies

Paratek Pharmaceuticals, Inc.President Oct 8, 2019 to Sep 21, 2023¹
Paratek Pharmaceuticals, Inc.VP & Chief Commercial Officer Apr 16, 2015 to Feb 28, 2019²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 21, 2023Returned to company 126,750 shares of Paratek Pharmaceuticals, Inc.³
Sep 21, 2023Returned to company 622,284 shares of Paratek Pharmaceuticals, Inc.³
Aug 8, 2023Granted 98,750 shares of Paratek Pharmaceuticals, Inc.⁴
Dec 21, 2022Sold 6,750 shares at $1.99 of Paratek Pharmaceuticals, Inc.⁵
Dec 20, 2022Granted 22,500 shares of Paratek Pharmaceuticals, Inc.⁵
Dec 13, 2022Sold 6,253 shares at $1.96 of Paratek Pharmaceuticals, Inc.⁶
Dec 12, 2022Sold 3,820 shares at $1.98 of Paratek Pharmaceuticals, Inc.⁶
Oct 28, 2022Sold 4,563 shares at $3.47 of Paratek Pharmaceuticals, Inc.⁷
Oct 25, 2022Granted 15,000 shares of Paratek Pharmaceuticals, Inc.⁸
Aug 8, 2022Granted 71,591 shares of Paratek Pharmaceuticals, Inc.⁹
Mar 15, 2022Granted 101,250 shares of Paratek Pharmaceuticals, Inc.¹⁰
Dec 15, 2021Sold 22,624 shares at $4.27 of Paratek Pharmaceuticals, Inc.¹¹
Dec 14, 2021Sold 10,946 shares at $4.37 of Paratek Pharmaceuticals, Inc.¹¹
Dec 13, 2021Sold 6,422 shares at $4.42 of Paratek Pharmaceuticals, Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.